Literature DB >> 12970736

Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells.

Caroline A Heckman1, Melissa A Wheeler, Linda M Boxer.   

Abstract

In follicular lymphomas with the t(14;18) translocation, there is increased expression of the bcl-2 gene, which is dependent upon regulatory elements within the bcl-2 5' flanking region and the immunoglobulin heavy-chain gene enhancers. We found that t(14;18) lymphomas expressed C/EBPalpha, which is not normally expressed in B lymphocytes. Expression of C/EBPalpha increased bcl-2 expression, and two regions of the bcl-2 P2 promoter that mediated this effect were identified. C/EBPbeta was also able to increase bcl-2 promoter activity through these sites. The 5' site was GC-rich and did not contain a C/EBP consensus sequence; however, C/EBP was observed to interact with this site both in vitro by EMSA and in vivo by chromatin immunoprecipitation assay. The 3' region contained the Cdx site, which mediates the effect of A-Myb on the bcl-2 promoter. In vivo binding studies revealed that C/EBP interacted with this region of the bcl-2 promoter as well. Decreased expression of C/EBP factors due to targeting of their transcripts by siRNA molecules resulted in downregulation of Bcl-2 protein. We conclude that C/EBPalpha and C/EBPbeta contribute to the deregulated expression of Bcl-2 in t(14;18) lymphoma cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970736     DOI: 10.1038/sj.onc.1206639

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  BCL-2 is a downstream target of ATF5 that mediates the prosurvival function of ATF5 in a cell type-dependent manner.

Authors:  Douglas Dluzen; Guangfu Li; Diana Tacelosky; Matthew Moreau; David X Liu
Journal:  J Biol Chem       Date:  2011-01-06       Impact factor: 5.157

2.  Deconvoluting the structural and drug-recognition complexity of the G-quadruplex-forming region upstream of the bcl-2 P1 promoter.

Authors:  Thomas S Dexheimer; Daekyu Sun; Laurence H Hurley
Journal:  J Am Chem Soc       Date:  2006-04-26       Impact factor: 15.419

3.  Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells.

Authors:  H Duan; H Xiang; L Ma; L M Boxer
Journal:  Oncogene       Date:  2008-08-11       Impact factor: 9.867

4.  Molecular symbiosis of CHOP and C/EBP beta isoform LIP contributes to endoplasmic reticulum stress-induced apoptosis.

Authors:  Calin-Bogdan Chiribau; Francesca Gaccioli; Charlie C Huang; Celvie L Yuan; Maria Hatzoglou
Journal:  Mol Cell Biol       Date:  2010-05-17       Impact factor: 4.272

5.  Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.

Authors:  Hong Duan; Caroline A Heckman; Linda M Boxer
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

6.  Intracellular insulin-like growth factor-1 induces Bcl-2 expression in airway epithelial cells.

Authors:  Hitendra S Chand; Jennifer Foster Harris; Yohannes Mebratu; Yangde Chen; Paul S Wright; Scott H Randell; Yohannes Tesfaigzi
Journal:  J Immunol       Date:  2012-03-28       Impact factor: 5.422

7.  IMiD immunomodulatory compounds block C/EBP{beta} translation through eIF4E down-regulation resulting in inhibition of MM.

Authors:  Shirong Li; Rekha Pal; Sara A Monaghan; Peter Schafer; Hongjiao Ouyang; Markus Mapara; Deborah L Galson; Suzanne Lentzsch
Journal:  Blood       Date:  2011-03-09       Impact factor: 22.113

8.  Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression.

Authors:  Christoph F A Vogel; Wen Li; Eric Sciullo; John Newman; Bruce Hammock; J Rachel Reader; Joseph Tuscano; Fumio Matsumura
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

9.  C/EBPbeta regulates transcription factors critical for proliferation and survival of multiple myeloma cells.

Authors:  Rekha Pal; Martin Janz; Deborah L Galson; Margarete Gries; Shirong Li; Korinna Jöhrens; Ioannis Anagnostopoulos; Bernd Dörken; Markus Y Mapara; Lisa Borghesi; Lela Kardava; G David Roodman; Christine Milcarek; Suzanne Lentzsch
Journal:  Blood       Date:  2009-08-28       Impact factor: 22.113

10.  DNA damage-binding complex recruits HDAC1 to repress Bcl-2 transcription in human ovarian cancer cells.

Authors:  Ran Zhao; Chunhua Han; Eric Eisenhauer; John Kroger; Weiqiang Zhao; Jianhua Yu; Karuppaiyah Selvendiran; Xingluo Liu; Altaf A Wani; Qi-En Wang
Journal:  Mol Cancer Res       Date:  2013-11-18       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.